Why CG Oncology Inc. (CGON) stock moved
CG Oncology Inc. (CGON) shares climbed 19.6% to $77.53 as of November 6, 2026, a sharp gain from the prior close of $64.80. BestStocks flagged the session as a major change for CGON. The move is tied to an earnings beat. Below, we break down what changed for CGON, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Beat
CG Oncology Inc. (CGON) reported EPS of −$0.64 vs. −$0.83 consensus estimate, beating by 23.3% on 2026-11-06. Next scheduled earnings announcement 2026-11-13.
What it means for CG Oncology Inc. investors
For CG Oncology Inc. investors, the balance of recent signals points to a strong bullish shift. On the constructive side: Earnings beat with positive market reaction; Strong 19.6% price move. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $86.50, implying +11.6% upside from $77.53. BestStocks rates the overall signal quality medium (75/100). With earnings due imminently, the next report is the most likely near-term test of the move.
CGON price reaction
CGON last traded at $77.53, up $12.73 (+19.64%) from the previous close of $64.80. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $59.85 and $77.53, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on CG Oncology Inc. (CGON)
The consensus analyst price target on CG Oncology Inc. (CGON) is $86.50, 11.6% above the recent $77.53. Here is how the bullish and bearish cases on CGON line up.
The bullish case
- Wall Street's consensus price target of $86.50 implies +11.6% upside from $77.53.
- The Street's most bullish target is $100.00 (+29.0%).
- Earnings beat with positive market reaction.
- Strong 19.6% price move.
- Positive price momentum.
The bearish case
- The bearish case is comparatively thin on recent signals; the main risk is that the climb toward the $86.50 consensus target has to be earned, and any of the risks BestStocks tracks could weigh on the shares.
Weighing both sides, BestStocks' composite read of recent signals is strongly bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 6, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CGON
In-depth CGON event analyses
Frequently asked questions about CGON
Why did CG Oncology Inc. (CGON) stock move?
CGON climbed 19.6% to $77.53. The move is associated with an earnings beat.
How much did CGON stock rise?
CGON gained 19.64% ($12.73) versus the prior close of $64.80, last trading at $77.53 on 1.2× average volume.
When is CG Oncology Inc.'s next earnings date?
CGON's next earnings report is scheduled for 2026-11-06 — about 0 days away.
What is the analyst price target for CGON?
The consensus analyst price target for CGON is $86.50, about 11.6% above the current $77.53. Over the past 90 days, analysts recorded 0 upgrades, 0 maintains, and 0 downgrades.
How BestStocks tracks CGON
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for CGON, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 6, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.